GB1387739A - Pyrimidine derivatives and process for preparing the same - Google Patents

Pyrimidine derivatives and process for preparing the same

Info

Publication number
GB1387739A
GB1387739A GB4335572A GB4335572A GB1387739A GB 1387739 A GB1387739 A GB 1387739A GB 4335572 A GB4335572 A GB 4335572A GB 4335572 A GB4335572 A GB 4335572A GB 1387739 A GB1387739 A GB 1387739A
Authority
GB
United Kingdom
Prior art keywords
amino
sept
acylation
cooh
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4335572A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Boseki Co Ltd
Original Assignee
Nitto Boseki Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7404171A external-priority patent/JPS50641B2/ja
Priority claimed from JP7423771A external-priority patent/JPS5220961B2/ja
Priority claimed from JP8266371A external-priority patent/JPS5118959B2/ja
Application filed by Nitto Boseki Co Ltd filed Critical Nitto Boseki Co Ltd
Publication of GB1387739A publication Critical patent/GB1387739A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/084—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/086—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB4335572A 1971-09-22 1972-09-19 Pyrimidine derivatives and process for preparing the same Expired GB1387739A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7404171A JPS50641B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-09-22 1971-09-22
JP7423771A JPS5220961B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-09-23 1971-09-23
JP8266371A JPS5118959B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-10-19 1971-10-19

Publications (1)

Publication Number Publication Date
GB1387739A true GB1387739A (en) 1975-03-19

Family

ID=27301388

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4335572A Expired GB1387739A (en) 1971-09-22 1972-09-19 Pyrimidine derivatives and process for preparing the same

Country Status (6)

Country Link
US (1) US3904612A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE789077A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH574939A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2154172A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1387739A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT965393B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083468A (en) * 1996-04-10 2000-07-04 Basf Aktiengesellschaft Method of manufacturing a hydrogenation catalyst

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO115498B1 (ro) * 1993-10-29 2000-03-30 Univ Boston Metoda de tratament a neoplasmului
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
CA2324426A1 (en) * 1998-02-11 1999-08-19 Douglas V. Faller Compositions and methods for the treatment of cystic fibrosis
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
WO2011038224A1 (en) 2009-09-24 2011-03-31 Trustees Of Boston University Methods for treating viral disorders
MA33899B1 (fr) 2009-12-08 2013-01-02 Hemaquest Pharmaceuticals Inc Procedes et regimes a faible dose pour des troubles des globules rouges
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
US20130273183A1 (en) 2012-04-13 2013-10-17 Eastman Chemical Company 2-Pyrimidine Thioesters and Thiocarbonates as Skin Brightening Agents
GB2567362B (en) 2016-07-15 2022-04-20 Nantkwest Inc HDAC inhibitors for use with NK cell based therapies
US20220226322A1 (en) 2019-05-31 2022-07-21 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565894A (en) * 1967-05-15 1971-02-23 Monsanto Co Pyrimidinyl esters of dithiocarbamic acids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083468A (en) * 1996-04-10 2000-07-04 Basf Aktiengesellschaft Method of manufacturing a hydrogenation catalyst

Also Published As

Publication number Publication date
US3904612A (en) 1975-09-09
DE2246334A1 (de) 1973-04-05
FR2154172A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-05-04
DE2246334B2 (de) 1976-03-25
CH574939A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-04-30
BE789077A (fr) 1973-01-15
IT965393B (it) 1974-01-31

Similar Documents

Publication Publication Date Title
GB1243169A (en) PRODUCTION OF alpha-L-ASPARTYL-L-PHENYLALANINE ALKYL ESTERS
PH21545A (en) Novel penicillins and pharmaceutically acceptable salts thereof which contain a mono- or di- oxo piperazino (thio)-carbonyl amino group in molecule
GB1180749A (en) A New Polycyclic Amine and Processes for its Production
GB1387739A (en) Pyrimidine derivatives and process for preparing the same
GB1464140A (en) Alpha-l-aspartyl-l-phenylalanine derivatives
GB1220623A (en) 0,4-dihydro-1-substituted-6,7-methylene-dioxy-4-oxo-3-quinoline carboxylic acid derivatives
GB1503680A (en) Pharmaceutical preparations having psychotropic activity and process for their manufacture
GB1154260A (en) N-Aromatically Substituted Acid Amides
US3856848A (en) Process for preparing a protected arginine
GB1496692A (en) Process for the preparation of ceph-2-em compounds
GB1192862A (en) Alkoxymethylamide Derivatives of Esters and/or Amides of Acids of Phosphorus
GB1322987A (en) On,n-diacylhydroxylamine derivatives and preparation
GB1494299A (en) Propionic acid derivative salts having hiperlipemic activity
GB1332833A (en) Amindines
GB1526038A (en) 5-thiazole methane amine derivatives and salts thereof processes for preparing them and pharmaceutical compositions containing them
ES481245A1 (es) Procedimiento mejorado para la preparacion de isocianatos.
GB1322069A (en) Aminoalkanoylaminocyclohexane derivatives
JPS5663973A (en) Novel thiadiazol-5-ylthiol ester and its preparation
GB1192248A (en) A process for the preparation of Novel Diphenylamine Derivatives
GB1185273A (en) Derivatives of Phthalimidines
GB1212613A (en) 4-quinazolone derivatives and process for the preparation thereof
GB1205519A (en) Novel 1,2-dihydro-benztriazine derivatives and process for preparing the same
KR800001704B1 (en) Process for preparing arginine salt of amoxycillin
GB1206185A (en) Process for the preparation of amine salts
GB1292094A (en) A phenylglycine derivative

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years